Cadrenal Therapeutics, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +56.4% | -5.1% | – | |
| – | – | – | – | |
| – | +938.9% | +3.0% | -2.5% | |
| – | – | +90.3% | +38.5% | |
| – | +182.7% | +43.6% | +22.8% | |
| – | – | – | – | |
| – | -84.0% | -100.0% | – | |
| – | – | – | – | |
| – | -4,147,975.0% | – | – | |
| – | – | – | – | |
| – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.